Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chinese Chronic Liver Failure Consortium Acute-on-Chronic Liver Disease and Failure Study --a Prospective Multi-center Study in China, the Largest Hepatitis B Virus High-endemic Region.

NCT02457637 is registered in ClinicalTrials.gov with Hai Li as lead sponsor.

NCT NCT02457637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02457637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chinese Chronic Liver Failure Consortium Acute-on-Chronic Liver Disease and Failure Study --a Prospective Multi-center Study in China, the Largest Hepatitis B Virus High-endemic Region.
Lead sponsor
Hai Li
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
December 31, 2019
Enrollment
2,600 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

liver failure, acute on chronic